PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0022658|nephropathy |
| Sentences | 14 |
| PubMedID- 23109331 | Contrast-induced nephropathy in patients with st elevation myocardial infarction treated with primary percutaneous coronary intervention. |
| PubMedID- 21742082 | Acute hyperglycemia: is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function. |
| PubMedID- 24021122 | Objective: to explore the association between high-sensitivity c-reactive protein (hs-crp) and contrast-induced nephropathy (cin) in patients with st-segment elevated myocardial infarction (stemi) undergoing percutaneous coronary intervention (pci) . |
| PubMedID- 21447654 | Patients with nephropathy or history of angina, acute myocardial infarction, or claudication were excluded. |
| PubMedID- 24920294 | Combination of hemoglobin and left ventricular ejection fraction as a new predictor of contrast induced nephropathy in patients with non-st elevation myocardial infarction. |
| PubMedID- 24714489 | Methods and results: a total of 720 patients were randomized in the prevention of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (cinstemi) trial. |
| PubMedID- 26116992 | Predictive value of gamma-glutamyl transferase levels for contrast-induced nephropathy in patients with st-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. |
| PubMedID- 23703775 | Age, glomerular filtration rate, ejection fraction, and the agef score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. |
| PubMedID- 24830418 | Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. |
| PubMedID- 23539615 | We assessed the impact of preprocedural high-sensitivity c-reactive protein (hscrp) on the incidence of contrast-induced nephropathy (cin) in patients with st-segment elevation myocardial infarction (stemi) undergoing primary percutaneous coronary intervention (p-pci). |
| PubMedID- 23620308 | We investigated the relationship between baseline neutrophil-to-lymphocyte ratio (nlr) and contrast-induced nephropathy (cin) in patients with st-segment elevation myocardial infarction (stemi). |
| PubMedID- 25032713 | Aims: to evaluate the efficacy of high-dose atorvastatin on contrast-induced nephropathy (cin) occurrence in patients with st-elevation myocardial infarction undergoing primary angioplasty. |
| PubMedID- 25790710 | [risk factors of contrast-induced nephropathy in patients with myocardial infarction]. |
| PubMedID- 25759106 | To investigate the role of hydration to prevent contrast-induced nephropathy (cin) in patients with st-segment elevation myocardial infarction (stemi) who underwent primary percutaneous coronary intervention (ppci), we prospectively included 408 consecutive patients who were randomly assigned to receive either hydration with isotonic saline (1 ml/kg/h since the beginning of the procedure and for 24 hours after it: ns+ group) or not (ns- group). |
Page: 1